Apparatus for controlling an analytical process in a sample-responsive device and method of use thereof

A single motor-driven apparatus with a clutch assembly and rotating wheel system addresses complexity and temperature control issues in point-of-care devices, enabling efficient reagent dispensing and rapid PCR cycles in microfluidic cartridges.

JP2024542068APending Publication Date: 2024-11-13NOVEL MICRODEVICES LLC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2024526475
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-11-01
Filing Date
2022-11-01
Publication Date
2024-11-13

AI Technical Summary

Technical Problem

Existing point-of-care sample-response devices face challenges with complex designs requiring multiple motors for reagent dispensing, leading to increased size, cost, and portability issues, and inaccurate temperature control due to poor heat transfer and predictive algorithms in molecular amplification processes.

Method used

A single motor-driven apparatus with a clutch assembly, drive belt, and actuation mechanism controls reagent dispensing and temperature regulation using a rotating wheel with a heating element and heat sink, enabling precise and efficient analytical processes in microfluidic cartridges.

Benefits of technology

The solution reduces device complexity, size, and cost while ensuring accurate temperature control and rapid analytical processes, such as PCR, with up to 40 cycles completed in less than 15 minutes, using a non-contact heating method and IR temperature sensing.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024542068000001_ABST
    Figure 2024542068000001_ABST
Patent Text Reader

Abstract

An apparatus is disclosed for controlling analytical processes performed by microfluidic cartridges for use in sample-responsive devices and point-of-care diagnostic devices, which controls sample dispensing into the microfluidic cartridge, transfer of magnetic bead-based analytes to the microfluidic cartridge, as well as nucleic acid sample preparation, amplification and detection processes.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to an apparatus and method for use for controlling an analytical process in a sample-responsive device.

[0002] CROSS-REFERENCE TO RELATED APPLICATIONS This application claims the benefit of priority to U.S. Provisional Application Nos. 63 / 274,507 and 63 / 274,510, filed November 1, 2021, the disclosures of which are incorporated by reference in their entireties as if fully set forth herein.

[0003] A general technical field is point-of-care sample-response devices that perform analyses within microfluidic cartridges and the components used to control the sequential dispensing of reagents and other analytical steps performed on the point-of-care sample-response devices. [Background technology]

[0004] Point-of-care (POC) devices enable rapid molecular diagnostic testing at the point of patient care. Such sample-to-response devices and associated procedures typically utilize molecular amplification techniques, such as PCR or isothermal amplification, and require control over the sequence of reagent dispensing and other analytical parameters.

[0005] Typically, liquid reagents are contained in a reagent blister on the microfluidic cartridge that has an opening to allow liquid to enter the cartridge. The opening is sealed with a rupturable membrane or layer. To dispense the liquid reagent into the cartridge, it is usually necessary to tear or break the rupturable membrane and crush the blister.

[0006] To fracture the reagent blisters to dispense the reagents, a force must be applied by structures configured to deform the reagent blisters under pressure. This is typically accomplished by individual geared motors controlling each actuation structure. However, complex cartridge designs, such as those that dispense multiple reagents from multiple reagent blisters in a predefined dispense sequence, require increased device complexity, such as the number of motors and drive assemblies required. This increases the size, cost, and portability of the device.

[0007] Analyses performed on sample-response devices often involve molecular amplification on the microfluidic cartridge depending on the assay. Most of these techniques use molecular amplification techniques such as PCR or isothermal amplification, which rely on heating the reaction for amplification (thermal cycling in the case of PCR).

[0008] Most sample-responsive devices employ resistive heaters. In resistive heating, an electric current is passed through a resistive element. This current is converted by the resistor into heat that is used to heat the amplification reaction. One problem with this method is that it requires precise contact between the reaction chamber on the microfluidic cartridge and the resistive heater element. Poor contact can result in poor heat transfer to the amplification chamber and failed amplification. To overcome this problem, few commonly used techniques embed resistive heater elements as part of the disposable cartridge. Another approach is to apply pressure to the amplification wells, causing them to bulge outward to improve contact with the heater element.

[0009] Another challenge with the contact approach is temperature control. In such a setup, a temperature sensor is placed on the heater element (instead of the fluid). This approach requires a predictive algorithm to determine the fluid temperature in the amplification chamber based on the heater element temperature and the ambient temperature. This can lead to inaccurate temperature control.

[0010] PCR thermal cycling technology uses "heat zones" and PCR reagents are moved between heat zones during the thermal cycling process. It is a fast technique but requires pumps and precise fluid movement control to ensure temperatures are maintained for the proper cycle times. Summary of the Invention [Problem to be solved by the invention]

[0011] In accordance with the present invention, various embodiments of an apparatus for controlling an analytical process carried out within a microfluidic cartridge are disclosed. [Means for solving the problem]

[0012] In one embodiment, an apparatus is provided for controlling an analytical process in a microfluidic cartridge. In some embodiments, the apparatus may be driven by a single motor. In one embodiment, the single motor may be a stepper motor, a servo motor, or a gear motor. In other embodiments, the single motor includes one gear and is configured to operate at one speed.

[0013] In other embodiments, the microfluidic cartridge can include one or more reagent-filled blisters, a fluid channel, and one or more wells or chambers. In other embodiments, the microfluidic cartridge can include a lateral flow strip. In yet other embodiments, the microfluidic cartridge can include one or more flow-through blisters. The one or more flow-through blisters can include an inlet valve and an outlet valve. In yet other embodiments, the one or more reagent-filled blisters comprise a breakaway blister.

[0014] The apparatus may further include a drive belt assembly, hi one embodiment, the drive belt assembly may include a single drive belt, hi another embodiment, the drive belt assembly may include a single shaft extending from the single motor.

[0015] The apparatus may further include a clutch assembly including one or more clutches configured to rotate about a central axis of rotation. In some embodiments, each clutch may include a drive shaft centrally disposed within a respective one of the one or more clutches on the central axis of rotation, and the rotation of the one or more clutches is driven by the drive belt assembly. In one embodiment, the clutch assembly includes multiple clutches. In another embodiment, the clutch assembly may include three clutches. In another embodiment, the one or more clutches are electromagnetic clutches. In some embodiments, a single shaft extending from the single motor is secured to only one of the multiple clutches to power the rotation of the drive belt assembly.

[0016] The device may further include an actuation mechanism comprising one or more actuating elements attached to the drive shaft configured to engage the microfluidic cartridge and actuate one or more analytical processes. In one embodiment, the one or more actuating elements may comprise one or more press plates. In other embodiments, the one or more press plates may comprise one or more protrusions configured to physically engage the microfluidic cartridge. In some embodiments, the one or more protrusions comprise a first feature configured to engage and open the inlet and outlet valves on the one or more flow-through blisters. In other embodiments, the one or more protrusions comprise a second feature configured to deform the one or more breakage blisters to force the reagent out of the breakage blisters. In other embodiments, the drive shaft may comprise a threaded portion for mounting the one or more actuating elements.

[0017] The device can further include a series of spatially-distributed permanent magnets located proximate to the microfluidic cartridge. In some embodiments, the microfluidic cartridge can include metal particles (e.g., metal beads) for binding to target analytes and moving the target analytes through the microfluidic cartridge. In other embodiments, the permanent magnets can be configured to move the metal particles through the microfluidic cartridge by magnetic forces. In one embodiment, the spatially-distributed permanent magnets can be attached to a rotating wheel located substantially coplanar adjacent to the microfluidic cartridge.

[0018] In another embodiment, a method of controlling an analytical process in a microfluidic cartridge is provided. The method may include providing an apparatus configured to be programmed with one or more sequence files corresponding to one or more analyses. The apparatus may further include the following components: a single motor; a drive belt assembly including the single drive belt; a clutch assembly including a plurality of clutches configured to rotate about a central axis of rotation, each clutch including a drive shaft centrally disposed within a respective one or more clutches on the central axis of rotation, the rotation of the plurality of clutches being driven by the drive belt assembly; and an actuation mechanism including one or more actuating elements attached to the drive shaft configured to engage the microfluidic cartridge and actuate one or more analytical processes. In some embodiments, the method may include programming the apparatus with one or more sequence files corresponding to one or more analyses. In other embodiments, the method may further include inserting the microfluidic cartridge into the apparatus and initiating the execution of the analyses using the apparatus. In some embodiments, the one or more analytical processes include polymerase chain reaction, magnetic bead-based migration of target analytes through the microfluidic cartridge, and / or lateral flow strip detection. In some embodiments, the detection procedure may be any of lateral flow strip detection, real-time optical fluorescence detection, optical microarray detection, and electrochemical detection.

[0019] In one embodiment, the device monitors and controls the temperature of a reaction, for example in a polymerase chain reaction. The device used may thus include a microfluidic cartridge, an actuation plate, and a temperature control unit comprising a heating element, a heat dissipation element, and a temperature sensor. In some embodiments, the temperature sensor comprises an IR temperature sensor.

[0020] In another embodiment, the microfluidic cartridge includes an amplification chamber in which an analytical reaction, such as PCR, takes place. In another embodiment, the heating element comprises an inductive coil element. In yet another embodiment, the inductive coil element comprises a bifilar coil. In yet another embodiment, the heating element can be attached to a rotating wheel that can be moved (e.g., rotated) relative to the cartridge. To facilitate rapid heating and cooling, this movement brings the heating element into close proximity to an amplification well when heating is required and removes the heating element when cooling. In a further embodiment, the heating element and the amplification chamber have an air gap between them and are not in physical contact.

[0021] In some embodiments, the heat dissipation element may be attached to the rotating wheel. In other embodiments, the heat dissipation element comprises a heat sink. In yet other embodiments, the heat sink comprises aluminum, iron-based metals, copper (combinations and alloys thereof), carbon-based materials in combination with aluminum, and / or natural graphite composites. In yet other embodiments, the performance of the heat dissipation element may be further enhanced by using a fan and / or water pump to induce convection cooling with either air or a coolant fluid. In further embodiments, a thermoelectric cooler (TEC) may be utilized with or without a fan / electrical element and heat sink combination to enhance the performance of the heat dissipation element.

[0022] In some embodiments, the temperature control unit further comprises a heat storage object. In other embodiments, the heat storage object is disposed within the amplification chamber or in contact with a wall of the amplification chamber to facilitate heat transfer to the fluid contained within the amplification chamber. In other embodiments, the heat storage object is disposed within the amplification chamber such that the reagent to be amplified is in direct contact with the front and / or rear surface of the heat storage object. In yet other embodiments, the heat storage object forms a pocket that contains the reagent to be amplified. This is accomplished by providing a recess within the object and allowing the reagent to flow within the recess. This increases the surface area in contact with the fluid, allowing for faster heat transfer. In yet other embodiments, the heat storage object may comprise fins that increase the surface area of ​​contact between the object and the fluid to be heated. In yet other embodiments, the heat storage object comprises a metal. In some embodiments, the metal is aluminum, aluminum alloys, ferrous metals and their alloys, copper, or combinations thereof. In yet other embodiments, the metal object may be coated with a polymer to modify its thermal inertia properties. In further embodiments, the heat storage object comprises a material having a predetermined thermal inertia property. In other embodiments, the material of the heat storage object has a high thermal inertia property. The heat storage object may be glued in the amplification chamber or may be welded to a plastic substrate of the microfluidic cartridge. In yet other embodiments, the heat storage object is suspended in the amplification chamber. In some embodiments, the temperature control unit is capable of heating and cooling the amplification reagents at a rate of up to about 15° C. per second. In yet other embodiments, the device can perform up to about 40 PCR cycles in less than 15 minutes.

[0023] In one embodiment, the device is incorporated into a sample-responsive and / or point-of-care device for performing a sample-responsive diagnostic assay.Thus, in one embodiment, a sample-responsive and / or point-of-care device for performing a diagnostic assay is contemplated that includes the device for controlling an analytical process within a microfluidic cartridge. [Brief description of the drawings]

[0024] Having thus described the presently disclosed subject matter in general terms, reference is now made to the accompanying drawings, which disclose exemplary embodiments of the invention. [Figure 1] FIG. 1 is a side perspective view of one embodiment of the overall device. [Diagram 2] FIG. 2 is a cross-sectional view showing one embodiment of a clutch system. [Diagram 3] FIG. 3 illustrates one embodiment of a clutch assembly, actuation element, and belt drive assembly. [Figure 4A] ~ [Figure 4B] 4A-4B show an embodiment of various components of an actuation mechanism having three actuation elements. [Figure 5A] ~ [Figure 5B] 5A-5B show an embodiment of a first actuation element and a microfluidic cartridge. [Figure 6A] ~ [Figure 6B] 6A-6B show an embodiment of a second actuation element and a microfluidic cartridge. [Figure 7A] ~ [Figure 7B] 7A-7B show an embodiment of a third actuation element and a microfluidic cartridge. [Figure 8A] ~ [Figure 8C] 8A to 8C are diagrams illustrating one embodiment of an electromagnetic clutch. [Figure 9A] ~ [Figure 9B] 9A-9B show one embodiment of a rotating wheel with permanent magnets attached and a microfluidic cartridge. [Figure 10] FIG. 10 shows one embodiment of a microfluidic cartridge incorporating an amplification chamber and a heat storage object. [Figure 11A] ~ [Figure 11C]11A-11C show one embodiment of a rotor fitted with a permanent magnet, a heating element and a heat sink in conjunction with a microfluidic cartridge. [Figure 12A] ~ [Figure 12C] 12A-12C show an embodiment of a spinning wheel fitted with permanent magnets, a heating element and a heat sink having a thermoelectric cooler (TEC) and a heat spreader. [Figure 13] FIG. 13 is a diagram illustrating one embodiment of a heating element, microfluidic cartridge, amplification chamber, heat storage object, and temperature sensor configuration. [Figure 14A] ~ [Figure 14E] 14A-14E are diagrams illustrating embodiments of the position and shape of the heat storage object within the amplification chamber. [Figure 15] FIG. 15 illustrates an embodiment depicting three target temperature regions in a segmented fluidic channel (with valves) and the movement of reagents through the channel from one region to the next. [Figure 16] FIG. 16 illustrates an embodiment depicting three target temperature regions in a continuous fluid channel (without valves) on a disk and the movement of reagents through the channels from one region to the next. [Figure 17] FIG. 17 shows lateral flow strips and electrophoretic images showing positive CT and NG objects according to an embodiment. [Figure 18A] ~ [Figure 18B] 18A-18B show a rotating wheel according to this embodiment both alone and in conjunction with a microfluidic cartridge. [Figure 19A] ~ [Figure 19C] 19A-19C show a rotating wheel and temperature sensor coupled to a microfluidic cartridge according to an embodiment. [Figure 20] FIG. 20 is a lateral flow strip image showing positive CT-11 after the analysis performed in the example. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0025] The subject matter of the present disclosure will now be described more fully with reference to the accompanying drawings, in which some, but not all, embodiments of the subject matter of the present disclosure are shown. The subject matter of the present disclosure may be embodied in many different forms and should not be construed as being limited to the embodiments set forth herein, but rather, these embodiments are provided so that this disclosure will satisfy applicable legal requirements. Indeed, many modifications and other embodiments of the subject matter of the present disclosure described herein will come to mind to one skilled in the art to which the subject matter of the present disclosure pertains having the benefit of the teachings presented in the foregoing descriptions and the associated drawings. Therefore, it is to be understood that the subject matter of the present disclosure is not limited to the specific embodiments disclosed, and that modifications and other embodiments are intended to be included within the scope of the appended claims.

[0026] Reagent dispensing control 1, an embodiment of an apparatus 100 used for controlled sequential reagent dispensing can generally include a clutch assembly, generally designated 101, a belt drive assembly, generally designated 102, and an actuation mechanism, generally designated 103. Apparatus 100 is configured to sequentially dispense reagents from one or more reagent dispensing units disposed on or within a microfluidic cartridge in a predetermined and controlled manner dictated in large part by the particular procedural requirements of the diagnostic assay being performed.

[0027] Referring to Figure 2, one embodiment of a clutch assembly 101 is illustrated. Although other clutch assembly designs may be used, the clutch assembly 101 illustrated in Figures 1-3 is an electromagnetic clutch assembly. In some embodiments, an electromagnetic clutch assembly such as those manufactured and sold by Ogura Industrial Corp., 100 Randolph Road, Somerset County, New Jersey, zip code 08873 (https: / / ogura-clutch.com) may be used. In particular, in some embodiments, a clutch assembly from the MIC electromagnetic micro-clutch product line manufactured by Ogura Industrial Corp. may be used. Other known manufacturers of micro electromagnetic clutch assemblies include, but are not limited to, Miki Pulley, US, 13200 Sixth Avenue North, Plymouth, Minnesota, USA, ZIP Code 55441, and Chain Tail Co., Ltd., No. 305, Lane 460, Sec. 1, Xinan Road, Wuri District, Taichung City, Taiwan, ZIP Code 41462. Other examples of electromagnetic clutch assemblies are disclosed in U.S. Patent Nos. 7,325,664, 6,997,294, 7,040,374, 8,235,196, 6,837,351, 7,581,628, and 6,823,974. Table 1 below provides exemplary technical specifications for electromagnetic clutches having torque parameters of 2.5, 3.5, and / or 5. Letter references, such as bore "d" and "t", are shown in Figures 8A-C.

[0028] [Table 1]

[0029] In one embodiment, the clutch assembly 101 may include one or more clutches 104 driven by a power source. In some embodiments, the clutch assembly 101 may be electromagnetically controlled. A single clutch 104 is shown in FIG. 2. As shown in FIG. 2, the clutch 104 may include a hub and rotor assembly 105 including a rotor 106 and a hub 107. Rotation of the rotor 106 may be driven by a drive belt assembly 102. In some embodiments, the drive belt assembly 102 may include a drive belt (e.g., a toothed drive belt) disposed about and engaged with an outer output surface of the rotor 106 that rotates the rotor 106 (or another output structure 135 connected to the rotor 106) as long as the drive belt assembly 102 is powered. In other embodiments, the hub 107 also rotates when the rotor 106 and hub 107 are mechanically engaged. In a related embodiment, the hub 107 may be transitioned from an engaged state (actuated or rotating) to a disengaged state (not actuated or stationary) via an electrical signal. In some embodiments, when the clutch 104 is in a de-energized or neutral state (i.e., no coupled rotation of the rotor and hub), the rotor 106 and hub 107 can be slidably engaged or completely disengaged from one another such that the rotor 106 can rotate freely under power while the hub 107 remains stationary. A bearing assembly can be used for the sliding engagement. In one embodiment, an electrical signal is sent to the hub 107, which magnetically drives components of the hub 107 into frictional engagement with the rotor 106, thereby causing the rotor 106 and hub 107 to rotate coupled. In some embodiments, the clutch 104 can house a drive shaft or rod 108 within a drive shaft housing 109 that is centrally located within the clutch 104 along an axis (A). As shown in FIG. 2, the drive shaft 108 can include a threaded portion 115 for mounting one or more actuating elements, such as those described below. The drive shaft housing 109 extends through both the rotor 106 and the hub 107 along the axis (A).

[0030] FIG. 1 illustrates a schematic of one embodiment of the apparatus. As discussed above, the apparatus may include a clutch assembly (generally designated 101), a belt drive assembly (generally designated 102), and an actuation mechanism (generally designated 103). In the embodiment illustrated in FIG. 1, a motor 110 is used to power a drive belt 111 via a drive shaft 113 (best shown in FIG. 3). In some embodiments, the motor 110 may be a servo motor, a stepper motor, a single phase gear motor, a DC motor, an AC induction motor, or the like. In other embodiments, the motor 110 may include a single gear and operate at a single speed. The drive belt 111 is shown attached to and wrapped around two output structures 135 that engage the illustrated rotor elements 106a-106b. The drive belt 111 may be attached to the output structures 135 that are configured to engage the rotor 106. Alternatively, the drive belt 111 may be attached to the rotor 106. In some embodiments, the motor 110 may include a single gear. Those skilled in the art will appreciate that additional pulleys and / or rotating components, such as the output structure described above that is configured to engage rotor 106, can be added in line with motor 110. For example, if tighter control over the angular position of the drive belt is desired, a servo motor can be used for closed loop control of the angular position of the belt and can also detect slippage of the belt on the rotor. This arrangement is useful when components other than a clutch rely on the rotation of the drive belt.

[0031] Continuing with reference to FIG. 1, the drive belt 111 may comprise a rubber drive belt. In other embodiments, the rubber drive belt may be toothed to reduce slippage. In other embodiments, a drive chain may be used to further reduce slippage. If a drive chain is used, the rotor 106 (or other output structure 135 configured to engage the rotor 106) may include gears or sprockets for chain engagement. As discussed above, engagement / disengagement of the hub 107 and rotor 106 is controlled by electrical signals and magnet actuation. When the hub 107 engages the rotor 106, the drive belt 111 rotates a clutch assembly including both the hub 107 and rotor 106, which may be described as a coupled rotation. The coupled rotation of the hub and rotor assembly induces linear motion (forward or backward) of the drive shaft 108 through the clutch components.

[0032] With reference to the embodiment shown in FIG. 3, one or more drive shafts 108 are engaged with (and, for example, anchored or mounted within) one or more actuating elements 112 within the sample-responsive diagnostic device. In the illustrated embodiment, there are three clutches 104a-104c, three drive shafts 108a-108c, and three actuating elements 112a-112c (also shown in FIGS. 4A-4B). Note that the three clutches, three drive shafts, and three actuating elements are driven by a single motor 110 and a single drive belt assembly 102. In this embodiment, the motor 110 directly powers the first clutch 104a via a drive shaft 113, causing the rotation of the clutch 104a. Rotation of the second clutch 104b and the third clutch 104c is achieved via a drive belt 111 that brings together the outputs of the rotors 106a-106c.

[0033] It should be noted that the single motor enhanced rotation of multiple clutches producing controlled actuation of multiple actuating elements significantly reduces the size, complexity, cost, and power requirements / consumption of the sample-responsive diagnostic device. Such a design results in a more compact and portable device without sacrificing the speed, accuracy, and efficiency of the diagnostic analysis. This precise control of a predetermined reagent dispensing sequence (adjustable depending on the diagnostic analysis) from a single microfluidic cartridge 116 using a single power supply provides a technical advantage over known sample-responsive devices.

[0034] With reference to the embodiment shown in FIGS. 3-6, the one or more actuating elements 112, in some embodiments, are press plates having one or more protrusions 113 configured to contact a reagent dispensing unit (RDU) on the microfluidic cartridge as the press plate moves towards the cartridge 116 surface via the drive shaft 108. As shown in FIGS. 4-6, each of the three press plates 112a-c can include one or more protrusions 113 on a press plate front surface 114 configured to apply pressure to a particular structural feature of the microfluidic cartridge 116. The one or more protrusions can be of uniform size and shape or can be of different sizes and shapes. Indeed, in some embodiments, one or more protrusions on a press plate are replaceable or interchangeable, i.e., can be removed and replaced with other protrusions (of different sizes and / or shapes) depending on the blister configuration of the microfluidic cartridge and / or the analytical procedure. Alternatively, the press plate itself can be removed from the threaded portion 115 of the drive shaft 108 and replaced or substituted with another plate including a different set of protrusions.

[0035] For example, some protrusions 113 are configured (size, shape, and overall design) to engage and open specific inlet and outlet port valves on flow-through blisters 138 (shown in FIGS. 4B and 5A ) located on the cartridge 116. In some embodiments, these protrusions can be, for example, elongated columnar extensions that apply pressure to a bead-containing container, causing the beads to burst a foil lid, thereby opening the inlet / outlet valves. Other protrusions 113 are configured to press and break (or deform) reagent-filled blisters, forcing the reagent contents out of the blister and into the microfluidic cartridge 116. In some embodiments, the size and shape of these protrusions depends on the configuration of the blisters on the cartridge 116.

[0036] In this manner, the sample-responsive device can be programmed in a predetermined manner such that each of the one or more actuating elements 112 actuates forward or backward to engage and / or disengage one or more blisters in the correct sequence required depending on the diagnostic analysis being performed. In this system, the amount of pressure applied to the blister can also be controlled, for example, by controlling the distance traveled by the press plate or the length of the protrusions used. Programmable software-driven microfluidic systems are described, for example, in Mezic et al., U.S. Patent Application Publication No. 2009 / 0038938, Microfluidic Central Processing Unit and Microfluidic Systems Architecture.

[0037] It should be noted that the actuation element 113 may further include one or more permanent magnets configured to engage and move the analyte-bound magnetic beads through the fluidic channels of the microfluidic cartridge 116. Magnetic beads with ionizable groups that have a net positive charge at a given pH are used to bind DNA. An example of such type of magnetic beads is the ChargeSwitch Magnetic bead (Life Technologies, Carlsbad, Calif.). DNA is bound to such type of magnetic beads in the presence of a binding buffer capable of generating a net positive charge on the beads, and the DNA is eluted in the presence of an elution buffer capable of generating a net neutral or negative charge on the beads. In this embodiment, chargeswitch magnetic beads are used that bind DNA to the beads in the presence of a buffer with a pH<5 and elute DNA from the beads in the presence of a buffer with a pH>8. The magnetic beads are moved sequentially through all the wells on the microfluidic cartridge by the method described in the present disclosure. DNA is first bound to the magnetic beads in the presence of a binding buffer. The beads are then moved in and out of two wells containing a wash buffer to wash impurities from the beads, which remain in the wash buffer solution. The washed beads are then transferred to a well containing an elution buffer, and the DNA is eluted from the beads into the elution buffer. The eluted DNA may be used to hydrate lyophilized reagents for nucleic acid amplification tests (NAATs). In some embodiments, the magnetic beads may be eluted directly into the amplification wells. One or more heaters are turned on as part of the automated sequence to provide temperature for amplification.

[0038] In some embodiments, the actuating element 112 or the microfluidic cartridge 116 is configured to rotate while remaining substantially flush with the actuating element or the microfluidic cartridge (depending on which one is capable of rotating). Alternatively, as shown in FIGS. 11A-11C, one or more spatially arranged permanent magnets can be disposed on a wheel 117 configured to rotate about an axis perpendicular to the microfluidic cartridge. While the wheel 117 rotates relative to the cartridge, the wheel and the microfluidic cartridge remain substantially flush with each other. As described above, the wheel 117 can include one or more permanent magnets 118 spatially arranged in a predetermined manner. In the embodiment shown in FIGS. 9 and 18, the wheel 117 includes seven magnets at specific locations on the face 119 of the wheel 117. In this embodiment, the microfluidic cartridge 116 does not rotate, the wheel 117 is disposed opposite the microfluidic cartridge 116 as the actuating element 112, and the permanent magnets 118 are disposed on the wheel face 119 closest to the microfluidic cartridge 116. The interactions between the wheel 117, the magnet 118, and the cartridge 116 are described in more detail in the examples below.

[0039] With continued reference to Figures 3-6, the press plates 112a-112c operate in a controlled, predetermined manner throughout the analysis process to move reagents through the cartridge at the correct time. For example, in an analysis requiring nucleic acid amplification, press plate 112a can be used to dispense liquid reagents into the wells, plate 112b can be used to fill the remaining volume of the cartridge with mineral oil, and plate 112c can be used to move the amplification products from the first channel of the cartridge to the lateral flow strip 133 of the cartridge. In this example, each press plate (and protrusions) can continue to apply pressure to the cartridge until a current limit programmed into the motor is reached and a message is sent that the plate is fully extended and in position. The final position of the plate can also be determined using a physical sensor, such as an end-stop toggle switch or a proximity sensor. In one embodiment, as briefly described above and in more detail in the examples below, the final steps in the analysis can be performed using permanent magnets spatially positioned at predetermined locations on a structure (e.g., rotating wheel 117) that engages magnetic beads bound to nucleic acid molecules with the rotation of the microfluidic cartridge. Following elution of the amplification products from the magnetic beads, the amplification products are transferred to a separate station for detection, which can be performed using processes such as lateral flow strip detection, real-time fluorescence detection, optical microarray detection, or electrochemical detection.

[0040] Temperature control - molecular amplification (PCR) The sample-responsive device also controls and regulates the temperature of reagents. More specifically, the sample-responsive device can regulate, heat, cool, and / or measure the temperature of reagents used in molecular amplification processes such as PCR. In one embodiment, the sample-responsive device applies a non-contact approach to heating and temperature measurement.

[0041] 10 shows a microfluidic cartridge 116 and an amplification chamber 121 (cross section through the center of the amplification well) located within the cartridge 116. In this embodiment, the reagent to be heated is located within the amplification chamber along with a heat storage object 122.

[0042] Referring now to FIG. 11, heating and temperature control requires a heating element 123. In some embodiments, the heating element 123 may be an electrical conductor such as a wire in the form of a coil, swirl, or helix. In other embodiments, the heating element 123 is an induction coil such as in the embodiment shown in FIGS. 11-13. In yet other embodiments, the induction coil 123 may be an electromagnetic coil such as a bifilar coil. In one embodiment, the induction coil 123 is located proximate to the amplification chamber 121. For example, referring to the embodiment shown in FIGS. 11-12, the induction coil 123 may be located on the rotating wheel (actuation wheel) 117 with the spatially separated permanent magnets 118a-118f. FIGS. 11A-11C show an example of a rotating wheel 117 carrying the induction coil 123 for a microfluidic cartridge 116 during normal operation.

[0043] Alternatively, the heating element may be a resistive heating element comprising a resistor embedded in a block of thermally conductive material such as a metal, metal oxide, or metal alloy. The heating element may also be a resistive thin film heating element or a Peltier element. In other embodiments, the heating element is a positive temperature coefficient self-regulating element. The heating element may be integrated as part of the microfluidic device and intended as a single-use, disposable element. In further embodiments, phase change materials may be used to generate thermal energy for lysis and sample transfer. Phase change materials are widely used in a variety of applications requiring thermal energy storage and have been developed for use over a wide temperature range (-40°C to 150°C and above). Phase change materials are advantageous because they provide high density energy storage and store heat within a narrow temperature range. Furthermore, they are cheap, non-toxic, and do not require electrical energy to generate heat. As such, phase change materials are an attractive option for point-of-care settings and disposable devices requiring thermal energy. In additional embodiments, phase change materials contained in a sealed pouch are used to form a covering sheath around a sample extraction vessel. The phase change material coating may be present as part of the microfluidic device or as part of the sample extraction reservoir. Connecting the sample extraction reservoir to the microfluidic device creates nucleation sites, activating the phase change material and increasing the temperature to heat the sample. This can be accomplished by enclosing a metal piece in a pouch containing the phase change material that snaps when the sample extraction reservoir is connected to the microfluidic device. The phase change material can also be actuated by an external actuator present on the actuation element of the microfluidic device. In some embodiments, a suitable phase change material may be activated to cool the sample to prevent its degradation. In some embodiments, the heating element may serve to perform NAAT on the microfluidic device as well as heat, dissolve and move the sample to a fluid well on the microfluidic device.

[0044] 10 and 14A-14E, in some embodiments, the sample-response device can include a thermal storage object 125 disposed in the amplification chamber 121 of the microfluidic cartridge 116. A variety of materials can be used for the thermal storage object 125, so long as the thermal storage object has certain properties, such as suitable thermal inertia. In some embodiments, the suitable thermal inertia is medium to low. In some embodiments, the thermal storage object includes a metal, such as aluminum, an aluminum alloy, or copper.

[0045] As shown in Figures 14B-14E, the position of the heat storage object 125 within the amplification chamber can be modified or changed. For example, as shown in Figure 14B, the heat storage object can be attached to the back surface 126 of the amplification chamber 121. In an alternative embodiment (Figure 14C), the heat storage object can be centrally located within the amplification chamber 121. The shape of the heat storage object 125 can be changed. For example, as shown in Figure 14D, the heat storage object 125 can substantially conform to the inner wall of the amplification chamber 121 and surround the reagents within the chamber. In other embodiments, the heat storage object 125 can be comb-shaped (Figure 14E). The versatility afforded by such modifications allows for a variety of analyses, and the determination of the modifications may depend on the analysis. By changing the size, shape, and / or position of the heat storage object within the amplification chamber, heating can be localized to a particular portion within the amplification chamber. In some embodiments, the localization of heat can be controlled by the shape, size / thickness, and thermal mass of the heat storage object. Such localized heating techniques have low thermal inertia and therefore facilitate rapid cooling, a feature that is extremely useful for PCR and thermal cycling processes.

[0046] With reference to the embodiment shown in FIG. 13, an oscillating signal can be provided to a heating element 123, which induces a current in a thermal storage object 125 contained within the amplification chamber. This rapidly heats the thermal storage object 125, which in turn heats the amplification reagents 127 in contact with the thermal storage object 125. It is important to note that in this embodiment, there is no contact between the heating element 123 and the thermal storage object 125 in the amplification chamber. Thus, such a heating strategy provides a non-contact method of heating the amplification wells on the microfluidic cartridge. Technical advantages of such an approach include rapid heating speed and reliable / repeatable heating of the amplification chamber 121 without the need for precise contact between the heating element 123 and the amplification wells 121.

[0047] Accurate control of reagent temperature during thermal cycling is important for successful PCR, and accurate temperature monitoring and measurement are necessary. Various temperature monitoring techniques are known to those skilled in the art, with some being more effective than others. In one embodiment, monitoring and measurement may be performed by one or more sensors or other means that do not contact the measurement target. FIG. 7B shows an embodiment of a temperature sensor 124 that can be used to measure the reagent temperature in the amplification chamber 121. In some embodiments, the temperature sensor 124 may be an infrared (IR) temperature sensor. In other embodiments (see, e.g., FIG. 7), the temperature sensor is located on the opposite side of the microfluidic cartridge from the rotating wheel 117 and the induction coil 123. In other embodiments, the temperature sensor 124 is located on one of the actuating elements 112 (e.g., 112c), as shown in FIGS. 7A-7B. In the embodiment shown in FIGS. 7B and 13, the temperature sensor 124 is not in contact with the amplification chamber, the heat storage target, or the reagents. The IR temperature sensor is typically an electronic, non-contact sensor that emits IR radiation. Two commonly used types of IR temperature sensors are standard IR sensors and quantum IR sensors.

[0048] As mentioned above, in one embodiment, an infrared (IR) temperature sensor 124 may be placed in close proximity to, i.e., within the field of view of, the amplification chamber 121 of the microfluidic cartridge. The amplification chamber 121 may be made of a material that allows the transmission of IR radiation, such as, by way of example, thin polycarbonate that is relatively transparent to IR radiation. In this manner, the IR sensor may measure the temperature of the fluid within the amplification chamber 121 for "true closed loop" temperature control. In other words, a closed loop temperature control system is created by the heating element 123 (e.g., a bifilar coil) and the temperature sensor 124 positioned on opposite sides of the amplification chamber 121 containing the heat storage target 125 and the reaction reagents.

[0049] In some embodiments, other temperature sensors may be suitable depending on the system requirements, for example, a thermocouple sensor, a thermistor sensor, a resistance temperature detector, or a semiconductor-based sensor may be used in some embodiments.

[0050] In one embodiment, the heating element and temperature sensor can be on either side of the amplification chamber, so long as the heating element is proximate to the heat storage object and the temperature sensor is proximate to the reagents, regardless of where they are located within the amplification chamber. In some embodiments, the heat storage object is located on the surface of the amplification chamber closest to the heating element, as shown in FIG. 13. In other embodiments, the heat storage object is an integral part of the chamber making up all or part of the surface. In embodiments where the heat storage object is located on the chamber surface, the thickness of the chamber material under the object may be less than other portions of the chamber to promote efficient heating.

[0051] Due to the low thermal inertia of the material of the heat storage object 125 (e.g., a metal object), effective temperature control for PCR thermal cycling (either two-stage or three-stage) can be achieved via a single heating element (e.g., an induction coil). The amount of heat generated by the single heating element 123 can itself be controlled to maintain different temperatures within the amplification chamber. In other embodiments, in some embodiments, multiple heating elements 123 can be used.

[0052] 11 and 12, the rotating wheel 117 is fitted with a heating element 123 (e.g., an induction coil) and a structure that acts as a path for heat to dissipate from the cartridge, such as a heat sink 128. Examples of materials for the heat sink 128 include aluminum, copper (combinations and alloys thereof), carbon-based materials combined with aluminum, and natural graphite composites. In this embodiment, the rotating wheel 117 is connected to a power source such that it rotates about its central axis relative to the microfluidic cartridge placed in front of it. In the embodiment shown in FIG. 7, a temperature sensor 124 can be attached to a structure located proximate to the amplification chamber 121 and used to monitor the temperature of the fluid within the cartridge. The temperature sensor 124 shown in this embodiment is attached to a structure located on the opposite side of the microfluidic cartridge (i.e., the amplification chamber 121) from the rotating wheel 117 carrying the heating element 123 and heat sink 128.

[0053] 11 and 12, in some embodiments, the heating element 123 and the heat sink 128 may be spatially oriented (e.g., the distance between them controlled) on the rotating wheel 117 such that as the wheel rotates, either the heating element 123 or the heat sink 128 contacts the amplification chamber 121 of the microfluidic cartridge, but not both at the same time. When the heating element 123 contacts the amplification chamber 121, the thermal storage object 125 in the cartridge is rapidly heated, which heats the reagent in contact with the thermal storage object 125. A temperature sensor 124 located in front of the amplification chamber 121 measures the temperature of the fluid contained therein. In some embodiments, if the thermal mass of the thermal storage object 125 and the volume of the fluid to be heated (locally in front of the object) are small, rapid heating rates of more than 10° C. / s can be achieved.

[0054] Continuing with reference to the embodiment shown in FIGS. 11A-11C, a heat sink 128 can be employed to rapidly reduce the temperature of the fluid. In this embodiment, the rotating wheel 117 is rotated so that the heat sink 128 is in contact with the amplification chamber 121. In this embodiment, the heat sink 128 rapidly removes heat from the reagents. In an alternative embodiment shown in FIGS. 12A-12C, a thermoelectric cooler (TEC) 129 can be employed to further improve the cooling rate. Cooling rates up to about 15° C. / sec have been observed using the configuration described herein, greatly improving PCR speed. For example, rapid PCR up to about 40 cycles in less than 15 minutes may be achieved using this novel configuration. In other embodiments, a heat spreader 130 can be used. In some embodiments, the heat sink 128, thermoelectric cooler (TEC) and heat spreader 130 are stacked, with the heat spreader 130 closest to the amplification chamber 121 and the thermoelectric cooler 129 between the heat sink 128 and the heat spreader 130. The heat spreader transfers energy as heat from a hotter heat source to a cooler heat sink or heat exchanger. The most common type of passive heat spreader is a plate or block of a material with high thermal conductivity, such as copper, aluminum or diamond. Active heat spreaders use an external power source to accelerate the transfer of heat. Thermoelectric coolers work by the Peltier effect. Generally, TECs have two sides, and when a direct current is passed through the device, heat is transferred from one side to the other. The hot side is usually attached to a heat sink to maintain the ambient temperature. Zhao, Dongliang. (May 2014). "A review of thermoelectric cooling: Materials, modeling and applications." Applied Thermal Engineering 66(1-2):15-24. doi:10.1016 / j.applthermaleng.2014.01.074.

[0055] FIG. 15 shows yet another embodiment in which multiple temperature target areas 136a-136c are used (three in this embodiment). The first temperature target area 136a heats the reagent contained in the first amplification chamber 121a (or other reagent well), the temperature target area 136b heats the reagent contained in the second chamber 121b, and the third temperature target area 136c heats the reagent contained in the third chamber 121c. To obtain the desired temperature, a single heating element 123 or multiple heating elements 123a-123c can be used. In one embodiment, the thermal mass (and therefore the thermal inertia) of the heat storage object 125 can be intentionally selected to be high in order to promote rapid heat transfer to the reagent while keeping the temperature of the heat storage object constant. Such a scenario is advantageous when reagents are transferred from one chamber / heat storage object to another. In this embodiment, multiple heat storage objects can be heated to different temperatures corresponding to the holding temperatures required for PCR thermal cycling. Fluid valves 131a-131b open and close to control the movement of reagents between the chambers containing heat storage objects 125a-125c. Although not shown in the figure, a fluid pump can also be used to generate pressure to move the reagents.

[0056] In yet another embodiment shown in FIG. 16, multiple temperature target areas 136a-136c (e.g., three in this embodiment) are disposed within a continuous (unvalved) fluid channel 132. In this embodiment, the flow rate of the reagent through the continuous (unvalved) fluid channel 132 may be constant. Furthermore, the length of the individual heat storage objects can be selected such that the time it takes for the reagent to pass through the individual objects corresponds to the retention time of the PCR process at a particular temperature. In some embodiments, the number of times the reagent moves (e.g., via a pump) around the continuous (unvalved) fluid channel 132 corresponds to the number of PCR cycles. Such a configuration does not require valves and can utilize a simple fluid pump to move the fluid through the objects on the track.

[0057] Example 1: Detection of Chlamydia and Gonorrhea in Samples Using a Sample-Response Assay Including PCR Amplification and Lateral Flow Detection The following is an example of an analysis involving PCR amplification and lateral flow analysis of the amplified products, performed using a device for controlling the analytical process performed in a sample-responsive device. The following description is an example of an important aspect of the invention described above.

[0058] Pooled negative vaginal swab samples were spiked with CT and NG cells. CT serotype E was spiked at 1.2 IFU / mL, NG WHО-L (ciprofloxacin resistant) at 5 CFU / mL, and NG ATCC 430669 (ciprofloxacin susceptible) at 106 CFU / mL. Samples were lysed and purified with charge-switch magnetic beads using applicant's proprietary system. The master mix included a multiplex 5 primer mix to amplify CT, NG, gyrA (ciprofloxacin resistance marker) and human GAPDH for sample integrity control, 1x platinum II PCR buffer (Thermos), 5.5 mM MgCl2, 10 U platinum II taq HS DNA polymerase, 120 mM Tris buffer pH 8.8, 0.75x platinum GC enhancer, and 2 μg / μL BSA. After the sample preparation steps, amplification was initiated by first heating to 95°C for 2 min to activate the hot-start DNA polymerase, followed by 40 thermal cycles at 95°C for 15 s and 62.5°C for 30 s. The amplified products were then analyzed by gel electrophoresis. First, 4 μL of the amplified products were mixed with 1 μL of 5× loading dye, then 3 μL was added to the gel well and run at 175 V for 13 min. After gel analysis, the amplified samples were further analyzed by lateral flow strips. Before the lateral flow analysis was performed, the samples were digested with lambda exonuclease enzyme to generate single-stranded DNA. Both gel analysis and lateral flow analysis showed the amplification of the corresponding targets. See Figure 17.

[0059] The microfluidic cartridge 116 shown in FIG. 18B contains all the components necessary to perform a sample-response assay. This cartridge facilitates sample purification, concentration, amplification, and finally detection of the amplification products. After lysis, the sample is transferred through a filter that separates cellular debris and other PCR inhibitors. The filtered, lysed sample is then passed through a magnetic bead blister where it is mixed with the charge-switched magnetic beads. The sample and magnetic bead mixture is transferred to the binding chamber of the cartridge through a debubbler filter that removes air bubbles and prevents air bubbles from entering the binding chamber. In the binding chamber, the lysed sample and magnetic beads are mixed with a binding reagent, which changes the pH of the mixture and causes the DNA in the sample to bind to the charge-switched magnetic beads. The magnetic beads (and the bound DNA) are then transferred to wash chambers 1 and 2. In these chambers, the magnetic beads interact with a wash buffer to remove any PCR inhibitors that may be captured by the magnetic beads. Finally, the beads are transferred to the amplification chamber 121 where they are suspended in a master mix. The pH of the master mix causes the DNA to elute from the magnetic beads. PCR thermal cycling was performed to amplify the DNA, in this example, and the amplified products were transferred to lateral flow strips 133 for detection.

[0060] A variety of methods can be used to detect the amplified products, including visual detection using pH-sensitive dyes or metal-sensitive indicators, electrochemical detection, optical detection using intercalating dyes or fluorescent probes, turbidimetry, and lateral flow strip detection. In this example, a lateral flow strip is used to detect the amplified nucleic acid. Biotin and FAM / FITC modified FIP and BIP primers, respectively, may be used in the LAMP reaction. A sandwiched format lateral flow test may be used. The amplified products may be mixed with dilution buffer or running buffer before lateral flow strip detection. A valve may be present and actuated as part of the analysis automation sequence to allow the amplified products to flow onto the lateral flow strip. Alternatively, a hole may be drilled in the septum to allow the amplified products to flow onto the lateral flow strip.

[0061] Applicant's device, embodying the apparatus described herein, was used to interact with a microfluidic cartridge to automate a sample-response test. The device included a cartridge feeding module, a blister / reagent dispensing module, a sample preparation and amplification module, and a detection module. The sample was added to the lysis chamber and the cartridge was partially inserted into the device. An RFID tag reader within the device read the RFID tag on the cartridge to identify the cartridge type. This is important so that the device can select and execute the appropriate analysis-specific sequence file.

[0062] The analytical steps performed by Applicant's apparatus in this embodiment are outlined by the example sequence file in Table 2 below, with supporting explanations below.

[0063] [Table 2A] [Table 2B]

[0064] The cartridge feed module accepts the microfluidic cartridge 116 and pulls it into the device. This module positions the cartridge in the device so that the remaining modules on the device can interact with it. In step 1 of the sequence file, the feed motor is turned on and the cartridge 116 is pulled into the device (Dir FM value is +1). See Table 2.

[0065] Next, the blister / reagent dispensing module (e.g., actuation mechanism 103) actuates plate 1 (e.g., 112a), rupturing the blister seals (e.g., the seals of the magnetic bead blister, wash blister 1, wash blister 2 and amplification buffer blister) and opening fluid flow paths from the reagent blisters to their respective chambers on the cartridge.

[0066] The air pump 137 is now activated for 30 seconds. See FIG. 5B and Table 2. This moves the sample in the lysis chamber through the sample filter, magnetic bead blister and debubble filter to the binding chamber of the cartridge. During these 30 seconds, the following steps are performed within the cartridge: i. The sample is lysed in a lysis chamber. ii. The lysed sample is passed through a sample filter to remove cellular debris. iii. The filtered lysate flows through the magnetic bead blister and mixes with the magnetic beads. iv. The lysate and magnetic bead mixture flows through a debubble filter to remove air bubbles from the sample. v. The mixture enters the binding chamber where it is mixed with a binding buffer reagent, causing the DNA in the sample to bind to the magnetic bead particles.

[0067] Next, the blister / reagent dispensing module (e.g., actuation mechanism 103) actuates plate 2 (e.g., press plate 112b). This plate impacts the reagent blister, deforming / breaking the blister, thereby dispensing the reagent contained in the blister into the cartridge. This fills the cartridge, i.e., the wash buffer blister dispenses into wash chambers 1 and 2, the amplification blister dispenses into amplification chamber 121, and the oil blister fills the first channel of the cartridge. Specifically, in step 2, the value of the actuation motor 110 (Act Mtr) is set to 1, the motor is activated, the value of the direction (Dir AM) is set to 1, the movement is towards the cartridge, the value of plate 1 is set to 1, and clutch 1 is activated to move plate 1. In step 3, the value of the air pump 137 is set to 1, the air pump is activated, the value of the hold time is set to 30, and the air pump is activated for 30 seconds. In step 4, the actuation motor (Act Mtr) value is set to 1 to activate the motor, the direction (Dir AM) value is set to 1 to move towards the cartridge, and the plate 2 112b value is set to 1 to activate clutch 2 104b to move plate 2 112b. See steps 2-4 in Table 2.

[0068] At this point, as shown in Figure 18A, the sample pre-conditioning and amplification wheel module (rotating wheel 117) moves relative to the cartridge to perform magnetic bead sample pre-conditioning. The sample pre-conditioning and amplification wheel contains spatially arranged magnets 118 for sample purification and enrichment. For amplification, the amplification wheel contains heater elements (inductive coils) 123 and heat sinks 128. In this example, the wheel moves relative to the microfluidic cartridge to present its magnets to the various chambers of the cartridge.

[0069] The following steps (see, e.g., steps 7-12 in Table 2) describe how DNA from a 650 uL sample is concentrated onto magnetic bead particles, purified by washing steps, and finally eluted into a 50 uL solution. Figures 18A-18B show a sample preparation and amplification wheel. Figure 18B also shows a microfluidic cartridge equipped with a wheel. In this example, the wheel rotates relative to the microfluidic cartridge to perform the magnetic bead-based sample concentration and purification. i. The wheel moves and the magnets on the wheel capture the magnetic bead particles in the binding chamber and draw them into the first channel of the microfluidic cartridge. ii. As the wheel continues to rotate clockwise, the magnetic bead particles are deposited on the baffle above wash well 1. iii. The wheel continues to rotate clockwise and another magnet on the wheel draws the magnetic bead particles into Wash Well 1 where the beads are resuspended in solution and washed. iv. As the wheel rotates further, the next magnet collects the magnetic bead particles from washing well 1 and transfers them onto washing well 2. v. The next magnet again transports the magnetic bead particles to washing well 2 for a washing step. vi. The wheel continues to rotate and the next magnet on the wheel collects the bead from wash well 2 and carries it to the amplification chamber. vii. A subsequent magnet carries the magnetic bead particles to the amplification chamber where they are resuspended in the master mix. viii. The pH of the master mix causes the DNA to elute from the magnetic beads into the master mix solution.

[0070] In this example, amplification on cartridge 116 is performed by thermal cycling of fluids in an amplification chamber. Heating is performed by inductive heating and cooling is performed by a heat sink cooled by a thermoelectric cooler. Steps 64 to 73 in Table 2 show a PCR thermal cycling sequence file. In general, the procedure is as follows: i. The actuator wheel 117 (see FIG. 18) rotates, presenting a heater element 123 to the cartridge's amplification chamber. In this example, the heater element is an induction heating coil attached to the actuator wheel. A metal object 125 is present in the cartridge's amplification chamber 121 and the coil induces heat into the metal object. Because the metal object is in direct contact with the fluid in the amplification chamber, the temperature of the fluid increases rapidly. ii. Figures 19A-19C show an IR sensor 124 placed in front of the amplification chamber 121. The IR sensor measures the temperature of the fluid within the amplification chamber. iii. In the assay used in this example, step 66 (see Table 2) moves the wheel to -386 degrees and presents an induction coil to the amplification chamber on the cartridge with a heater set point temperature (HTR1SP) value of 95°C and a hold time value of 120 seconds. The induction coil thus heats the fluid until the IR sensor measures the temperature of the fluid and it reaches 95°C. Once at 95°C, the coil retains the heat so the fluid is held at that temperature for 120 seconds. Step 66 defines the thermal activation step. iv. In step 67, the wheel is moved to -424 degrees and a heat sink is presented to the amplification chamber of the cartridge. The heat sink is cooled to 4°C by a thermoelectric cooler (TEC). The heat sink contacts the amplification chamber and draws heat from the system, cooling the fluid to 62°C. v. In step 68, the wheel is returned to -386 degrees and the induction coil is presented to the amplification chamber. In this step, the induction coil adds heat to the system to hold the frits at 62.5°C for 30 seconds. Step 68 defines the annealing / extension step of PCR. vi. In step 69, the fluid temperature is increased to 95° C. Step 69 defines the denaturation step of the PCR. vii. After completion of step 69, the sequence file indicates that the next step is 64, to be repeated 39 times. Running these steps results in 40 cycles of PCR from 95°C to 65°C, including a denaturation step at 95°C for 5 seconds and an annealing / extension at 62.5°C for 30 seconds.

[0071] After amplification, the PCR products are transferred from the amplification chamber to the lateral flow strip 133 on the cartridge. See Figures 19A-19C which show plate 3 112c of the blister / reagent dispensing module positioned in front of the lateral flow strip blister 134. As shown in Figure 7A, protrusions 113 on plate 3 (112c) collide with the lateral flow blister 134 as plate 3 112c moves towards the front of the cartridge. The process is explained more clearly below. i. Plate 3 on the blister / reagent dispensing module moves to the front of the cartridge and the protrusions on Plate 3 impact the lateral flow blister, rupturing the blister and opening a fluid pathway from the amplification chamber to the lateral flow strip. ii. Once the fluid pathway is opened, the weight of the mineral oil above the PCR products provides the pressure head necessary to move the PCR products from the amplification chamber, through the lateral flow blister and into the lateral flow strip. iii. The lateral flow blister contains a lipophilic / hydrophobic pad, which allows the aqueous PCR product to flow through the blister while the mineral oil is trapped by the lipophilic pad, so that only 50uL or less of the amplified product flows into the lateral flow strip. iv. On a lateral flow strip, the PCR product passes through the strip and, if the target pathogen is present, it binds to a line on the strip and is visible. v. The strips are imaged with a camera and pathogen detection is done by image processing of the lateral flow strip images, see Figure 19 showing a CT11 positive sample.

[0072] Although the above examples specifically describe the use of the polymerase chain reaction (PCR), other NAATs are contemplated. Recent advances in isothermal amplification assay technology have simplified the equipment required to perform NAATs.

[0073] Example 2 - Amplification Profile a) Multiplex PCR amplification of CT / NG in vaginal swab samples In this example, CT and NG cells were spiked into pooled negative vaginal swab specimens. CT serоvar E had a yield of 1.2 IFU / mL, NG WHО-L (ciprofloxacin-resistant) had a yield of 5 CFU / mL, and NG ATCC 430669 (ciprofloxacin-susceptible) had a yield of 10 6CFU / mL were added. Samples were lysed and purified with charge-switch magnetic beads using NovelDx's proprietary system. The master mix contained a multiplex 5 primer mix for amplifying CT, NG, gyrA (ciprofloxacin resistance marker) and human GAPDH for sample integrity control, 1x platinum II PCR buffer (Thermos), 5.5 mM MgCl2, 10 U platinum II taq HS DNA polymerase (Thermos), 120 mM Tris buffer pH 8.8, 0.75x platinum GC enhancer, and 2 μg / μL BSA. After sample preparation steps, the hot-start DNA polymerase was activated by first heating at 95°C for 2 min, and then amplification was initiated by thermal cycling 40 times at 95°C for 15 s and 62.5°C for 30 s. The amplified products were then analyzed by gel electrophoresis using the FlashGel® System (Lonza). First, 4 μL of the amplified products were mixed with 1 μL of 5× FlashGel® loading dye (Lonza), and 3 μL was added to the gel well and run at 175 V for 13 min. After gel analysis, the amplified samples were further analyzed by lateral flow strips. The samples were digested with lambda exonuclease enzyme to generate single-stranded DNA before being subjected to lateral flow analysis. Both gel analysis and lateral flow analysis confirmed the amplification of the corresponding targets.

[0074] b) Rapid RT-PCR amplification of SARS-CоV-2 genomic RNA To demonstrate that the NovelDx platform can rapidly amplify specific target sequences, we used two primers specific for SARS-CoV-2 to amplify 92-bp and 112-bp target sequences. We used the 2x ready mix One Step PrimeScript® III RT-PCR kit (Cat.♯RR600B, Takara Bio) enhanced with high-speed SpeedStar DNA polymerase (Takata Bio). The total volume of the 50-μL amplification mix consisted of 14.6 μL water, 25 μL One Step PrimeScript® III RT-PCR mix, 5 μL primer 1 and primer 2 (1 μM each), 0.4 μL SpeedStar DNA Polymerase (5 U / μL), and 5 μL gRNA (1000, 100, or 10 copies / reaction). 50 μL was added to the amplification chamber of the cartridge, and the reverse transcription step was performed by heating at 55 ° C for 2 minutes to synthesize cDNA, and then heating at 95 ° C for 10 seconds to inactivate the RT enzyme and activate the hot start DNA polymerase. Then, PCR amplification was performed by repeating 40 cycles of 95 ° C for 1 second and 65 ° C for 3 seconds, and the total time of RTPCR amplification was about 10.5 minutes. The amplified product was then analyzed by gel electrophoresis using FlashGel (registered trademark) System (Lonza). First, 4 μL of the amplified product was mixed with 1 μL of 5 × FlashGel (registered trademark) loading dye (Lonza), and 3 μL was added to the gel well and electrophoresed at 175 V for 13 minutes. As a result of gel analysis, two bands corresponding to the 92 bp and 108 bp amplified products were observed below and above the 100 bp DNA marker for the 1000 and 100 copies of gRNA markers. A very faint band is seen in the 10 copy case, but no band is seen in the NTC sample.

[0075] Exemplary embodiments 1. An apparatus for controlling an analytical process in a microfluidic cartridge, comprising: A single motor; a drive belt assembly including a single drive belt; a clutch assembly including one or more clutches configured to rotate about a central axis of rotation, each clutch including a drive shaft centrally disposed within a respective one of the one or more clutches on the central axis of rotation, the rotation of the one or more clutches being driven by the drive belt assembly; an actuation mechanism comprising one or more actuating elements attached to the drive shaft configured to engage the microfluidic cartridge and actuate one or more analytical processes; An apparatus comprising:

[0076] 2. The apparatus of paragraph 1, wherein the one or more actuating elements include a press plate.

[0077] 3. The device of paragraph 1, wherein the microfluidic cartridge comprises one or more reagent-filled blisters, a fluid channel, and one or more wells.

[0078] 4. The apparatus of paragraph 2, wherein the press plate comprises one or more protrusions configured to physically engage with the microfluidic cartridge.

[0079] 5. The device of paragraph 4, wherein the microfluidic cartridge comprises one or more flow-through blisters having inlet and outlet valves, and the one or more protrusions have a first shape configured to engage and open the inlet and outlet valves.

[0080] 6. The device of paragraph 4, wherein the microfluidic cartridge comprises one or more reagent-filled crush blisters, and the one or more protrusions have a second shape configured to deform the one or more crush blisters to force the reagent out of the crush blisters.

[0081] 7. The apparatus of paragraph 1, wherein the drive shaft includes a threaded portion for mounting the one or more actuating elements.

[0082] 8. The device of paragraph 1, wherein the clutch assembly comprises a plurality of clutches.

[0083] 9. The device of paragraph 1, wherein the clutch assembly includes three clutches.

[0084] 10. The apparatus of paragraph 8, wherein the single motor has a shaft fixed to only one of the plurality of clutches to power rotation of the drive belt assembly.

[0085] 11. The apparatus of paragraph 9, wherein the single motor has a shaft fixed to only one of the plurality of clutches to power rotation of the drive belt assembly.

[0086] 12. The apparatus of paragraph 3, further comprising a series of spatially arranged permanent magnets in proximity to the microfluidic cartridge, the microfluidic cartridge further containing metal particles, the permanent magnets configured to move the metal particles through the microfluidic cartridge by magnetic force.

[0087] 13. The apparatus of paragraph 12, wherein the series of spatially-disposed permanent magnets are attached to a rotating wheel adjacent to the microfluidic cartridge.

[0088] 14. The device of paragraph 1, wherein the one or more clutches are electromagnetic clutches.

[0089] 15. The apparatus of paragraph 1, wherein the single motor is a stepper motor.

[0090] 16. The apparatus of paragraph 1, wherein the single motor is a servo motor.

[0091] 17. The apparatus of paragraph 1, wherein the single motor is a gear motor.

[0092] 18. The apparatus of paragraph 1, wherein the single motor includes one gear and is configured to operate at one speed.

[0093] 19. A method of controlling an analytical process in a microfluidic cartridge, comprising: providing an apparatus configured to be programmed with one or more sequence files corresponding to one or more analyses; programming the instrument with one or more sequence files corresponding to the one or more analyses; the apparatus comprises a single motor; a drive belt assembly including a single drive belt; a clutch assembly including a plurality of clutches configured to rotate about a central axis of rotation, each clutch including a drive shaft centrally disposed within a respective one of the one or more clutches on the central axis of rotation, the rotation of the plurality of clutches being driven by the drive belt assembly; and an actuation mechanism including one or more actuating elements attached to the drive shaft configured to engage the microfluidic cartridge and actuate one or more analytical processes; inserting the microfluidic cartridge into the device; initiating performance of the analysis using the device; A method comprising:

[0094] 20. The method of paragraph 19, wherein the one or more analytical processes comprises a polymerase chain reaction.

[0095] 21. The method of paragraph 19, wherein the one or more analytical processes include magnetic bead-based movement of target analytes through the microfluidic cartridge.

[0096] 22. The method of paragraph 19, wherein the one or more analytical processes includes a lateral flow strip analysis.

[0097] 23. An apparatus for controlling an analytical process in a microfluidic cartridge, comprising: a microfluidic cartridge; a temperature sensor; and a rotating wheel that rotates relative to the cartridge, the rotating wheel comprising a heating element and a heat dissipation element.

[0098] 24. The apparatus of paragraph 23, wherein the assay is a polymerase chain reaction.

[0099] 25. The device of paragraph 24, wherein the microfluidic cartridge comprises an amplification chamber in which PCR takes place.

[0100] 26. The apparatus of paragraph 23, wherein the heating element comprises an induction coil element.

[0101] 27. The apparatus of paragraph 23, wherein the heating element is attached to the rotating wheel.

[0102] 28. The apparatus of paragraph 23, wherein the heat dissipation element is attached to the rotating wheel.

[0103] 29. The apparatus of paragraph 26, wherein the induction coil element comprises a bifilar coil.

[0104] 30. The device of paragraph 23, wherein the heat dissipation element comprises a heat sink.

[0105] 31. The apparatus of paragraph 23, wherein the heat dissipation element comprises a heat sink, a thermoelectric cooler, and / or a heat spreader.

[0106] 32. The apparatus of paragraph 30, wherein the heat sink comprises aluminum, copper (combinations and alloys thereof), carbon-based materials in combination with aluminum, and / or natural graphite composite materials.

[0107] 33. The apparatus of paragraph 23, wherein the temperature control unit further comprises a heat storage object.

[0108] 34. The apparatus of paragraph 33, wherein the heat storage object is disposed within the amplification chamber.

[0109] 35. The device of paragraph 33, wherein the heat storage object comprises a metal.

[0110] 36. The apparatus of paragraph 33, wherein the heat storage object is provided on a wall of the amplification chamber, the wall being closest to the heating element.

[0111] 37. The apparatus of paragraph 35, wherein the metal is aluminum, an aluminum alloy, copper, an iron metal or an iron alloy, or a combination thereof.

[0112] 38. The device of paragraph 33, wherein the heat storage object comprises a material having predetermined thermal inertia characteristics.

[0113] 39. The device of paragraph 38, wherein the material of the heat storage object has high thermal inertia characteristics.

[0114] 40. The device of paragraph 23, wherein the temperature sensor comprises an IR temperature sensor.

[0115] 41. The apparatus of paragraph 25, wherein the heat source and the amplification chamber are not in physical contact.

[0116] 42. The apparatus of paragraph 25, wherein the temperature sensor and the amplification chamber are not in physical contact.

[0117] 43. The apparatus of paragraph 23, wherein the temperature control unit is capable of generating heating and cooling rates of the amplification reagents of between about 10° C. per second and about 50° C. per second.

[0118] 44. The device of paragraph 23, configured to achieve a reaction speed of about 40 cycles of PCR in less than 5 minutes to less than 15 minutes.

[0119] 45. The device of paragraph 19, wherein the one or more analytical processes are selected from the group consisting of lateral flow strip detection, real-time optical fluorescence detection, optical microarray detection, and electrochemical detection.

[0120] 46. ​​A microfluidic cartridge for use in a sample-responsive device, comprising: a microfluidic cartridge comprising a reagent blister and a fluidic channel, the reagent blister including a first reservoir, a second reservoir, a third reservoir, an inlet connection to allow reagent to enter the blister, an outlet connection to allow reagent to exit the blister and enter a fluidic channel, and a burst bar; a first plunger, a second plunger, and a third plunger; A microfluidic cartridge comprising:

[0121] 47. A sample-response device comprising: a microfluidic cartridge comprising a reagent blister and a fluidic channel, the reagent blister including a first reservoir, a second reservoir, a third reservoir, an inlet connection to allow reagent to enter the blister, an outlet connection to allow reagent to exit the blister and enter a fluidic channel, and a burst bar; a first plunger, a second plunger, and a third plunger; A sample-response device comprising:

[0122] Based on the above disclosure, it will be apparent to one of ordinary skill in the art that the above disclosed apparatus for controlling analytical processes in a microfluidic cartridge may be adapted for use in a point-of-care sample-response device or instrument. Accordingly, the invention described herein is also directed to a point-of-care device or instrument (or sample-response device or instrument) that includes an apparatus for controlling analytical processes in a microfluidic cartridge.

[0123] General definition Although specific terms are employed herein, they are used in a generic and descriptive sense only and not for purposes of limitation. Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the subject matter described herein belongs.

[0124] As used herein, "nucleic acid" refers to a polymeric compound comprising covalently linked subunits called nucleotides. A "nucleotide" is a molecule or individual unit within a larger nucleic acid molecule comprising a nucleoside (i.e., a compound comprising a purine or pyrimidine base linked to a sugar, usually ribose or deoxyribose) linked to a phosphate group.

[0125] "Polynucleotide" or "oligonucleotide" or "nucleic acid molecule" refers to the phosphate ester polymeric forms of ribonucleosides (adenosine, guanosine, uridine or cytidine, "RNA molecule" or simply "RNA") or deoxyribonucleosides (deoxyadenosine, deoxyguanosine, deoxythymidine or deoxycytidine, "DNA molecule" or simply "DNA") in either single-stranded or double-stranded form, or their phosphate ester analogs, such as phosphorothioates and thioesters. Polynucleotides of any length, including RNA, DNA, or RNA / DNA hybrid sequences, can be used. Polynucleotides for use in the present invention can be naturally occurring, synthetic, recombinant, in vitro produced, or a combination thereof, and can be purified using any purification method known in the art. Thus, the term "DNA" includes, but is not limited to, genomic DNA, plasmid DNA, synthetic DNA, semi-synthetic DNA, complementary DNA ("cDNA," DNA synthesized from a messenger RNA template), and recombinant DNA (DNA that has been artificially designed and thus has undergone molecular biological manipulation from a naturally occurring nucleotide sequence).

[0126] "Amplify," "amplification," "nucleic acid amplification," and the like refer to the production of multiple copies of a nucleic acid template (e.g., a template DNA molecule) or the production of multiple copies of a nucleic acid sequence complementary to a nucleic acid template (e.g., a template DNA molecule).

[0127] The terms "top," "bottom," "upper," "lower," and "above" are used throughout this specification with reference to the relative positions of components of the devices being described, e.g., the relative positions of an upper substrate and a lower substrate within the device, it being understood that the device will function regardless of orientation in space.

[0128] "Beads" with respect to beads on a droplet actuator means any bead or particle capable of interacting with a droplet on or in proximity to the droplet actuator. Beads may be of any of a wide variety of shapes, such as spherical, generally spherical, ovoid, discoid, cubic, amorphous, or other three-dimensional shapes. Beads may be configured with respect to the droplet actuator in a manner that allows, for example, a droplet on the droplet actuator to undergo droplet operations or allows a droplet on the droplet actuator to contact beads on the droplet actuator and / or beads outside the droplet actuator. Beads may be provided within a droplet, within a droplet operations gap, or on a droplet operations surface. Beads may be provided within a reservoir that is external to the droplet operations gap or spaced apart from the droplet operations surface, and the reservoir may be associated with a flow path that allows droplets containing beads to enter the droplet operations gap or contact the droplet operations surface. Beads may be manufactured using a wide variety of materials, such as, for example, resins, polymers, etc. The beads may be of any suitable size, e.g., microbeads, microparticles, nanobeads, nanoparticles, etc. In some cases the beads are magnetically responsive, while in other cases the beads are not significantly magnetically responsive. In the case of magnetically responsive beads, the magnetically responsive material may comprise substantially all of the bead, may comprise a portion of the bead, or may comprise only a component of the bead. The remainder of the bead may include, among other things, polymeric materials, coatings, sites allowing attachment of analytical reagents, etc.Examples of suitable beads include flow cytometry microbeads, polystyrene microparticles and nanoparticles, functionalized polystyrene microparticles and nanoparticles, coated polystyrene microparticles and nanoparticles, silica microbeads, fluorescent microspheres and nanospheres, functionalized fluorescent microspheres and nanospheres, coated fluorescent microspheres and nanospheres, color-dyed microparticles and nanoparticles, magnetic microparticles and nanoparticles, superparamagnetic microparticles and nanoparticles (e.g., DYNABEADS® particles available from Invitrogen Group, Carlsbad, Calif.), fluorescent microparticles and nanoparticles, coated magnetic microparticles and nanoparticles, ferromagnetic microparticles and nanoparticles, and coated ferromagnetic microparticles and nanoparticles. Beads may be pre-coupled with biomolecules or other substances capable of binding to biomolecules to form complexes. The beads may be pre-coupled with antibodies, proteins, antigens, DNA / RNA probes, or molecules that have affinity for the desired target.

[0129] "Immobilized" with respect to magnetically responsive beads means that the beads are substantially constrained in position within a droplet or within a filler fluid on a droplet actuator. For example, in one embodiment, the immobilized beads are sufficiently constrained in position within a droplet to enable a droplet splitting operation to be performed, resulting in droplets that include substantially all of the beads and droplets that are substantially devoid of beads.

[0130] "Magnetic responsive" means responsive to a magnetic field. "Magnetic responsive beads" include or are composed of a magnetically responsive material. Examples of magnetically responsive materials include paramagnetic materials, ferromagnetic materials, ferrimagnetic materials, and metamagnetic materials. Examples of suitable paramagnetic materials include iron, nickel, cobalt, and metal oxides such as Fe304, BaFe12019, CO, NiO, Mn203, Cr203, and COMnP.

[0131] When any form of liquid (e.g., a droplet or a continuum, whether moving or stationary) is described as being "on," "at," or "above" an electrode, array, matrix, or surface, such liquid may be in direct contact with the electrode / array / matrix / surface, or in contact with one or more layers or membranes interposed between the liquid and the electrode / array / matrix / surface. As an example, a filler liquid may be considered as a membrane between such liquid and the electrode / array / matrix / surface.

[0132] Following long-standing patent law convention, the terms "a," "an," and "the" refer to "one or more" when used in this application, including the claims. Thus, for example, a reference to "a subject" includes a plurality of subjects unless the context clearly indicates the contrary (e.g., a plurality of subjects, etc.).

[0133] Throughout this specification and claims, the terms "comprise," "comprises," and "comprising" are used in a non-exclusive sense, unless the context otherwise requires. Similarly, the term "include" and grammatical variations thereof are intended to be non-limiting, and the recitation of items in a list does not exclude other similar items that may be substituted for or added to the listed items.

[0134] For purposes of this specification and the appended claims, unless otherwise indicated, all numbers expressing quantities, sizes, dimensions, ratios, shapes, formulations, parameters, percentages, parameters, amounts, properties, and other numerical values ​​used in the specification and claims are understood to be modified in all instances by the term "about," even if the term "about" is not expressly stated in conjunction with a value, amount, or range. Thus, unless indicated to the contrary, the numerical parameters set forth in the following specification and the appended claims are not, and need not be, precise, but may be approximate and / or larger or smaller as desired, reflecting tolerances, conversion factors, rounding, measurement errors, and the like, as well as other factors known to those of ordinary skill in the art depending upon the desired properties sought to be obtained by the presently disclosed subject matter. For example, when referring to a value, the term "about" can be meant to encompass variations from the stated amount of, in some embodiments, ±100%, in some embodiments, ±50%, in some embodiments, ±20%, in some embodiments, ±10%, in some embodiments, ±5%, in some embodiments, ±1%, in some embodiments, ±0.5%, and in some embodiments, ±0.1%, as appropriate for practicing the disclosed methods or employing the disclosed compositions.

[0135] All publications, patent applications, patents, and other references mentioned herein (including references to specific commercial products or product lines) are indicative of the level of skill of those skilled in the art to which the presently disclosed subject matter pertains. All publications, patent applications, patents, and other references are incorporated herein by reference to the same extent as if each individual publication, patent application, patent, and other reference was specifically and individually indicated to be incorporated by reference. Although a number of patent applications, patents, and other references have been referenced herein, it will be understood that such reference is not an admission that any of these documents form part of the general knowledge in the art.

[0136] Although the foregoing subject matter has been described in some detail by way of illustration and example, for purposes of clarity of understanding, it will be understood by those skilled in the art that certain changes and modifications can be practiced within the scope of the appended claims.

Claims

1. 1. An apparatus for controlling an analytical process in a microfluidic cartridge, comprising: A single motor; a drive belt assembly including a single drive belt; a clutch assembly including one or more clutches configured to rotate about a central axis of rotation, each clutch including a drive shaft centrally disposed within a respective one of the one or more clutches on the central axis of rotation, the rotation of the one or more clutches being driven by the drive belt assembly; an actuation mechanism comprising one or more actuating elements attached to the drive shaft configured to engage the microfluidic cartridge and actuate one or more analytical processes; An apparatus comprising:

2. The apparatus of claim 1 , wherein the one or more actuating elements comprise a press plate.

3. The device of claim 1 , wherein the microfluidic cartridge comprises one or more reagent-filled blisters, a fluid channel, and one or more wells.

4. The apparatus of claim 2 , wherein the press plate comprises one or more protrusions configured to physically engage the microfluidic cartridge.

5. 5. The device of claim 4, wherein the microfluidic cartridge comprises one or more flow-through blisters comprising inlet and outlet valves, and the one or more protrusions comprise a first shape configured to engage and open the inlet and outlet valves.

6. 5. The device of claim 4, wherein the microfluidic cartridge comprises one or more reagent-filled crush blisters, and the one or more protrusions comprise a second shape configured to deform the one or more crush blisters to force the reagent out of the crush blisters.

7. The apparatus of claim 1 , wherein the drive shaft includes a threaded portion for mounting the one or more actuating elements.

8. The apparatus of claim 1 , wherein the clutch assembly comprises a plurality of clutches.

9. 2. The apparatus of claim 1, wherein said clutch assembly comprises three clutches.

10. 9. The apparatus of claim 8, wherein the single motor includes a shaft fixed to only one of the plurality of clutches for powering rotation of the drive belt assembly.

11. 10. The apparatus of claim 9, wherein the single motor includes a shaft fixed to only one of the plurality of clutches for powering rotation of the drive belt assembly.

12. 4. The apparatus of claim 3, further comprising a series of spatially arranged permanent magnets in proximity to the microfluidic cartridge, the microfluidic cartridge further comprising metal particles, the permanent magnets configured to move the metal particles through the microfluidic cartridge by magnetic force.

13. The apparatus of claim 12 , wherein the series of spatially-disposed permanent magnets are attached to a rotating wheel adjacent to the microfluidic cartridge.

14. The apparatus of claim 1 , wherein the one or more clutches are electromagnetic clutches.

15. The apparatus of claim 1 , wherein the single motor is a stepper motor.

16. The apparatus of claim 1 , wherein the single motor is a servo motor.

17. The apparatus of claim 1 , wherein the single motor is a gear motor.

18. 10. The apparatus of claim 1, wherein the single motor includes one gear and is configured to operate at one speed.

19. 1. A method for controlling an analytical process in a microfluidic cartridge, comprising: providing an apparatus configured to be programmed with one or more sequence files corresponding to one or more analyses; programming the instrument with one or more sequence files corresponding to the one or more analyses; the apparatus comprises a single motor; a drive belt assembly including a single drive belt; a clutch assembly including a plurality of clutches configured to rotate about a central axis of rotation, each clutch including a drive shaft centrally disposed within a respective one of the one or more clutches on the central axis of rotation, the rotation of the plurality of clutches being driven by the drive belt assembly; and an actuation mechanism including one or more actuating elements attached to the drive shaft configured to engage the microfluidic cartridge and actuate one or more analytical processes; inserting the microfluidic cartridge into the device; initiating performance of the analysis using the device; A method comprising:

20. 20. The method of claim 19, wherein the one or more analytical processes comprises a polymerase chain reaction.

21. 20. The method of claim 19, wherein the one or more analytical processes comprises magnetic bead-based movement of target analytes through the microfluidic cartridge.

22. 20. The method of claim 19, wherein the one or more analytical processes comprises a lateral flow strip analysis.

23. An apparatus for controlling an analytical process in a microfluidic cartridge, comprising: a microfluidic cartridge; a temperature sensor; and a rotating wheel that rotates relative to the cartridge, the rotating wheel comprising a heating element and a heat dissipation element.

24. 24. The device of claim 23, wherein the analysis is a polymerase chain reaction.

25. 25. The apparatus of claim 24, wherein the microfluidic cartridge comprises an amplification chamber in which PCR is performed.

26. 24. The apparatus of claim 23, wherein the heating element comprises an induction coil element.

27. 24. The apparatus of claim 23, wherein the heating element is attached to the rotating wheel.

28. 24. The apparatus of claim 23, wherein the heat dissipation element is attached to the rotating wheel.

29. 27. The apparatus of claim 26, wherein the inductive coil element comprises a bifilar coil.

30. 24. The apparatus of claim 23, wherein the heat dissipation element comprises a heat sink.

31. 24. The apparatus of claim 23, wherein the heat dissipation element comprises a heat sink, a thermoelectric cooler, and / or a heat spreader.

32. 31. The apparatus of claim 30, wherein the heat sink is comprised of aluminum, copper (combinations and alloys thereof), carbon-based materials in combination with aluminum, and / or natural graphite composite materials.

33. 24. The apparatus of claim 23, wherein the temperature control unit further comprises a heat storage object.

34. 34. The apparatus of claim 33, wherein the heat storage object is disposed within the amplification chamber.

35. The apparatus of claim 33 , wherein the heat storage object comprises a metal.

36. 34. The apparatus of claim 33, wherein the heat storage object is provided on a wall of the amplification chamber, the wall being closest to the heating element.

37. 36. The apparatus of claim 35, wherein the metal is aluminum, an aluminum alloy, copper, an iron metal and an iron alloy, or a combination thereof.

38. 34. The apparatus of claim 33, wherein the heat storage object comprises a material having predetermined thermal inertia properties.

39. 39. The apparatus of claim 38, wherein the material of the heat storage object has high thermal inertia properties.

40. 24. The apparatus of claim 23, wherein the temperature sensor comprises an IR temperature sensor.

41. 26. The apparatus of claim 25, wherein the heat source and the amplification chamber are not in physical contact.

42. 26. The apparatus of claim 25, wherein the temperature sensor and the amplification chamber are not in physical contact.

43. 24. The apparatus of claim 23, wherein the temperature control unit is capable of producing heating and cooling rates of the amplification reagents of between about 10 degrees Celsius per second and about 50 degrees Celsius per second.

44. 24. The apparatus of claim 23, configured to achieve a reaction rate of about 40 cycles of PCR in less than 5 to less than 15 minutes.

45. 20. The device of claim 19, wherein the one or more analytical processes are selected from the group consisting of lateral flow strip detection, real-time optical fluorescence detection, optical microarray detection, and electrochemical detection.

46. A sample-responsive device comprising: A sample-responsive device comprising an apparatus for controlling an analytical process within a microfluidic cartridge, the apparatus comprising: a single motor; a drive belt assembly including a single drive belt; a clutch assembly including one or more clutches configured to rotate about a central axis of rotation, each clutch including a drive shaft centrally disposed within a respective one or more clutches on the central axis of rotation, the rotation of the one or more clutches being driven by the drive belt assembly; and an actuation mechanism including one or more actuating elements attached to the drive shaft configured to engage the microfluidic cartridge and actuate one or more analytical processes.

47. A point-of-care diagnostic device, 1. A point-of-care diagnostic device comprising: an apparatus for controlling an analytical process within a microfluidic cartridge, the apparatus comprising: a single motor; a drive belt assembly including a single drive belt; a clutch assembly including one or more clutches configured to rotate about a central axis of rotation, each clutch including a drive shaft centrally disposed within a respective one of the one or more clutches on the central axis of rotation, the rotation of the one or more clutches being driven by the drive belt assembly; and an actuation mechanism including one or more actuating elements attached to the drive shaft configured to engage the microfluidic cartridge and actuate one or more analytical processes.